New drug approvals

国家药监局药审中心副主任杨志敏则表示，2025年，我国共有248个新药通过临床试验获批上市，涵盖了抗肿瘤、内分泌、精神障碍等18个适应症领域。

The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.

1 record reports a different value for this same indicator, region and period. We keep both rather than choosing or averaging. The disagreement is itself information.

Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.

APA

National Healthcare Security Administration. (2025). 国家医疗保障局 医保动态 从“0”到“1”创新能力增强 我国新药研发热度持续攀升. Retrieved September 17, 2026, from http://www.nhsa.gov.cn/art/2026/6/23/art_14_21076.html. Via StatOrigin, https://statorigin.org/stat/stat_Z2KY4SRVRS4V0XV5GA0GNYZG8F

Copy

MLA

National Healthcare Security Administration. "国家医疗保障局 医保动态 从“0”到“1”创新能力增强 我国新药研发热度持续攀升." 2025, http://www.nhsa.gov.cn/art/2026/6/23/art_14_21076.html. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_Z2KY4SRVRS4V0XV5GA0GNYZG8F.

Copy

Chicago

National Healthcare Security Administration. "国家医疗保障局 医保动态 从“0”到“1”创新能力增强 我国新药研发热度持续攀升." 2025. http://www.nhsa.gov.cn/art/2026/6/23/art_14_21076.html. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_Z2KY4SRVRS4V0XV5GA0GNYZG8F.

Copy

BibTeX

@misc{nhsa2025drugnyzg8f, author = {{National Healthcare Security Administration}}, title = {国家医疗保障局 医保动态 从“0”到“1”创新能力增强 我国新药研发热度持续攀升}, year = {2025}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_Z2KY4SRVRS4V0XV5GA0GNYZG8F}, note = {Original source: http://www.nhsa.gov.cn/art/2026/6/23/art\_14\_21076.html. Accessed September 17, 2026.} }

Copy

Everything needed to check this number yourself, without taking our word for it.

Record last modified 17 September 2026. Value type: actual. Update cadence: annual. This page is permanently addressable at statorigin.org/stat/stat_Z2KY4SRVRS4V0XV5GA0GNYZG8F.